Resolvin E1 (RvE1) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes
Open Access
- 25 March 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (7) , 6094-6103
Abstract
Resolution of inflammation is now known to be an active process which in part is instigated and controlled by specialized pro‐resolving lipid mediators (SPM's) derived from dietary omega‐3 fatty acids. Resolvin E1 (RvE1) is one of these SPM's derived from the omega‐3 fatty acid eicosapentaenoic acid. Using both molecular and phenotypic functional measures we report that in a model of Lipopolysaccharide (LPS) induced inflammation, RvE1 attenuated mRNA levels of both interlukin‐6 and monocyte chemoattractant protein‐1 whilst having no effect on tumor necrosis factor‐α or interlukin‐1β in C2C12 skeletal muscle myotubes. Findings at the molecular level were transferred into similar changes in extracellular protein levels of the corresponding genes with the greatest attenuation being noted in IL‐6 protein concentrations. RvE1 instigated beneficial morphological changes through the prevention of LPS induced skeletal muscle atrophy, in tandem with attenuation of the LPS induced reduction in contractile force in tissue engineered skeletal muscle. These findings demonstrate, in our model of endotoxin induced inflammation in skeletal muscle, that RvE1 has pro‐resolving properties in this cell type. Our data provides rationale for further investigation into the mechanistic action of RvE1 in skeletal muscle, with the vision of having potential benefits for the prevention/resolution of in‐vivo skeletal muscle atrophy.Keywords
This publication has 45 references indexed in Scilit:
- Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxificationProceedings of the National Academy of Sciences, 2010
- Resolvin E1 Receptor Activation Signals Phosphorylation and PhagocytosisJournal of Biological Chemistry, 2010
- The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung InjuryThe Journal of Immunology, 2009
- Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle CellsDiabetes, 2009
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiationLipids in Health and Disease, 2008
- Association between muscular strength and mortality in men: prospective cohort studyBMJ, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-κB and CalcineurinInfection and Immunity, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001